Penetrance and Phenotype of the Cys433Arg Myocilin Mutation in a Family Pedigree with Primary Open-Angle Glaucoma

PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic ner...

Full description

Saved in:
Bibliographic Details
Published in:Journal of glaucoma Vol. 12; no. 2; pp. 104 - 107
Main Authors: de Vasconcellos, José Paulo Cabral, de Melo, Mônica Barbosa, Schimiti, Rui, Costa, Fernando Ferreira, Costa, Vital Paulino
Format: Journal Article
Language:English
Published: United States Lippincott Williams & Wilkins, Inc 01-04-2003
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members. RESULTSOf the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4). CONCLUSIONThe Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance
AbstractList PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members. RESULTSOf the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4). CONCLUSIONThe Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance
To evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. Primary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members. Of the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4). The Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance
PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members. RESULTSOf the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4). CONCLUSIONThe Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance
Author Schimiti, Rui
Costa, Vital Paulino
de Vasconcellos, José Paulo Cabral
Costa, Fernando Ferreira
de Melo, Mônica Barbosa
AuthorAffiliation Departments of Ophthalmology and ‡Clinical Medicine - Hemocentro, University of Campinas, Campinas, †Department of Physiology, Santa Casa de São Paulo, and §Department of Ophthalmology, University of São Paulo, São Paulo, Brazil
AuthorAffiliation_xml – name: Departments of Ophthalmology and ‡Clinical Medicine - Hemocentro, University of Campinas, Campinas, †Department of Physiology, Santa Casa de São Paulo, and §Department of Ophthalmology, University of São Paulo, São Paulo, Brazil
Author_xml – sequence: 1
  givenname: José Paulo
  surname: de Vasconcellos
  middlename: Cabral
  fullname: de Vasconcellos, José Paulo Cabral
  organization: Departments of Ophthalmology and ‡Clinical Medicine - Hemocentro, University of Campinas, Campinas, †Department of Physiology, Santa Casa de São Paulo, and §Department of Ophthalmology, University of São Paulo, São Paulo, Brazil
– sequence: 2
  givenname: Mônica
  surname: de Melo
  middlename: Barbosa
  fullname: de Melo, Mônica Barbosa
– sequence: 3
  givenname: Rui
  surname: Schimiti
  fullname: Schimiti, Rui
– sequence: 4
  givenname: Fernando
  surname: Costa
  middlename: Ferreira
  fullname: Costa, Fernando Ferreira
– sequence: 5
  givenname: Vital Paulino
  surname: Costa
  fullname: Costa, Vital Paulino
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12671463$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtv1DAQxy1URB_wFZBP3ELH8SPZ42pFS6VW3QNI3CyvPdkEHHtrO1rl2xPYBU4cRjMj_ef1m2tyEWJAQiiDjwxWzS0AKMZWbVUDcBBLWi0G_BW5YpKrSrTs28USg2wqaOvVJbnO-TtADXXN3pBLVquGCcWvyMsWA5ZkgkVqgqPbHkMs8wFp7GjpkW7mLDhfpz19mqMd_BDo01RMGWKgS2zonRkHP9MtumGfEOlxKD3dpmE0aabPBwzVOuw90ntvJhtH85a87ozP-O7sb8jXu09fNp-rx-f7h836sbJcKl5JgbJDaICtXCdrBU61DiUXvDVWcOfMckwDUnbGwQ52yJTl7a5BxmwtWstvyIdT30OKLxPmoschW_TeBIxT1g1nqpZMLcL2JLQp5pyw04fT9pqB_oVb_8Gt_-LWv3Evpe_PM6bdiO5f4ZnvIhAnwTH6gin_8NMRk-7R-NLr_72R_wR3BYt7
CitedBy_id crossref_primary_10_1080_13816810_2018_1546405
crossref_primary_10_1086_421533
crossref_primary_10_1371_journal_pone_0207409
crossref_primary_10_1080_13816810_2021_2021427
crossref_primary_10_1111_j_1463_5224_2008_00631_x
crossref_primary_10_1016_j_exer_2005_11_002
crossref_primary_10_3390_molecules16075402
crossref_primary_10_1016_j_gene_2013_02_054
crossref_primary_10_1038_s41598_019_51281_y
crossref_primary_10_1080_08820530701745199
Cites_doi 10.1086/338709
10.1111/j.1749-6632.1998.tb10585.x
10.1093/oxfordjournals.aje.a113626
10.1056/NEJM199804093381503
10.1016/S0161-6420(01)00654-6
10.1021/bi00102a004
10.1086/340733
10.1006/geno.1997.4682
10.1038/1203
10.1093/hmg/8.5.899
10.1136/bjo.80.5.389
10.1074/jbc.273.11.6341
10.1073/pnas.90.10.4655
10.1016/S0161-6420(13)31615-7
10.1126/science.275.5300.668
10.1002/(SICI)1096-8628(19980413)76:5<438::AID-AJMG13>3.0.CO;2-N
10.1038/ng0593-47
10.1056/NEJM199304153281507
10.1177/002215540004801003
10.1017/S0016672300004584
10.1093/hmg/10.2.117
10.1016/S0002-9394(00)00536-5
10.1016/S0014-5793(97)00934-4
10.1093/hmg/6.10.1667
10.1074/mcp.M200023-MCP200
10.1136/jmg.37.4.301
ContentType Journal Article
Copyright 2003 Lippincott Williams & Wilkins, Inc.
Copyright_xml – notice: 2003 Lippincott Williams & Wilkins, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1097/00061198-200304000-00003
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-481X
EndPage 107
ExternalDocumentID 10_1097_00061198_200304000_00003
12671463
00061198-200304000-00003
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
.Z2
0R
2V-
53G
5GY
5VS
8L-
AAMTA
AARTV
AAYEP
ABBUW
ABOCM
ABXRP
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACWDW
ACWRI
ACXNZ
ADFPA
ADNKB
AE3
AENEX
AFUWQ
AHULI
AHVBC
AJIOK
AJNYG
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BQLVK
C45
CS3
DU5
DUNZO
E.X
EBS
EJD
EX3
F2K
F2L
F5P
FL-
H0
H0~
HZ
IN
IN~
JK3
JK8
K8S
KD2
KMI
L-C
N9A
N~M
O9-
OCUKA
ODA
OHASI
OL1
OLG
OLV
OLW
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OXXIT
P-K
P2P
R58
RIG
RLZ
RSW
S4R
S4S
V2I
WOQ
WOW
X3V
X3W
Z2
---
.-D
0R~
AAAAV
AAHPQ
AAIQE
AASCR
ABASU
ABDIG
ABJNI
ABVCZ
ACCJW
ACGFO
ACILI
ACXJB
ADGGA
ADHPY
AE6
AEETU
AFDTB
AGINI
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
ALMTX
AMKUR
AMNEI
AOHHW
BS7
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
NPM
OJAPA
TEORI
TSPGW
W3M
YFH
ZB8
ZFV
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3563-54e5fe07019df5260d68de53438ac43dda2027055fad0b0be16c38b7e11c248c3
ISSN 1057-0829
IngestDate Fri Aug 16 04:37:51 EDT 2024
Fri Aug 23 03:40:08 EDT 2024
Sat Sep 28 07:46:52 EDT 2024
Thu Aug 13 19:45:28 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3563-54e5fe07019df5260d68de53438ac43dda2027055fad0b0be16c38b7e11c248c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12671463
PQID 73162516
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_73162516
crossref_primary_10_1097_00061198_200304000_00003
pubmed_primary_12671463
wolterskluwer_health_00061198-200304000-00003
ProviderPackageCode L-C
C45
AARTV
ADFPA
ASCII
OLG
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
OLV
8L-
OLW
OLZ
F2K
F2L
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
AJIOK
OPUJH
V2I
S4R
S4S
DUNZO
OVDNE
AMJPA
OVD
AHULI
ACEWG
.Z2
AWKKM
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
ABXRP
AAMTA
E.X
OCUKA
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
ACWDW
PublicationCentury 2000
PublicationDate 2003-April
2003-Apr
2003-04-00
20030401
PublicationDateYYYYMMDD 2003-04-01
PublicationDate_xml – month: 04
  year: 2003
  text: 2003-April
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of glaucoma
PublicationTitleAlternate J Glaucoma
PublicationYear 2003
Publisher Lippincott Williams & Wilkins, Inc
Publisher_xml – name: Lippincott Williams & Wilkins, Inc
References Rozsa (R18-3) 1998; 4
Vasconcellos (R17-3) 2000; 37
Stone (R7-3) 1999; 275
Copin (R25-3) 2002; 70
Kulkarni (R31-3) 2000; 76
Nguuen (R9-3) 1998; 273
Swiderski (R11-3) 2000; 41
Kubota (R8-3) 1997; 41
Karavanich (R29-3) 1998; 855
Karali (R10-3) 2000; 41
Sheffield (R6-3) 1993; 4
Synder (R26-3) 1991; 30
Leske (R3-3) 1983; 118
Vicent (R24-3) 2002; 70
Morissete (R23-3) 1998; 19
Alward (R14-3) 1998; 338
Br??zin (R22-3) 1998; 76
Fingert (R15-3) 1999; 8
Craig (R21-3) 2001; 108
Ueda (R13-3) 2000; 48
Green (R32-3) 2002; 1
Jacobson (R33-3) 2001; 10
Quigley (R4-3) 1993; 328
Shimizu (R19-3) 2000; 130
Mukhopadhyay (R30-3) 2002; 8
Ortego (R12-3) 1997; 413
Yokoe (R27-3) 1993; 90
Fautsch (R28-3) 2001; 42
Quigley (R1-3) 1996; 80
Johnson (R5-3) 1993; 100
Sarfarazi (R16-3) 1997; 6
Allingham (R20-3) 1998; 39
References_xml – volume: 70
  start-page: 448
  year: 2002
  ident: R24-3
  publication-title: Am J Hum Genet
  doi: 10.1086/338709
  contributor:
    fullname: Vicent
– volume: 855
  start-page: 294
  year: 1998
  ident: R29-3
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1998.tb10585.x
  contributor:
    fullname: Karavanich
– volume: 118
  start-page: 166
  year: 1983
  ident: R3-3
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a113626
  contributor:
    fullname: Leske
– volume: 338
  start-page: 1022
  year: 1998
  ident: R14-3
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199804093381503
  contributor:
    fullname: Alward
– volume: 108
  start-page: 1607
  year: 2001
  ident: R21-3
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(01)00654-6
  contributor:
    fullname: Craig
– volume: 30
  start-page: 9143
  year: 1991
  ident: R26-3
  publication-title: Biochemistry
  doi: 10.1021/bi00102a004
  contributor:
    fullname: Synder
– volume: 8
  start-page: 271
  year: 2002
  ident: R30-3
  publication-title: Mol Vis
  contributor:
    fullname: Mukhopadhyay
– volume: 39
  start-page: 2288
  year: 1998
  ident: R20-3
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Allingham
– volume: 70
  start-page: 1575
  year: 2002
  ident: R25-3
  publication-title: Am J Hum Genet
  doi: 10.1086/340733
  contributor:
    fullname: Copin
– volume: 41
  start-page: 360
  year: 1997
  ident: R8-3
  publication-title: Genomics
  doi: 10.1006/geno.1997.4682
  contributor:
    fullname: Kubota
– volume: 19
  start-page: 319
  year: 1998
  ident: R23-3
  publication-title: Nat Genet
  doi: 10.1038/1203
  contributor:
    fullname: Morissete
– volume: 8
  start-page: 899
  year: 1999
  ident: R15-3
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/8.5.899
  contributor:
    fullname: Fingert
– volume: 80
  start-page: 389
  year: 1996
  ident: R1-3
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.80.5.389
  contributor:
    fullname: Quigley
– volume: 273
  start-page: 6341
  year: 1998
  ident: R9-3
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.11.6341
  contributor:
    fullname: Nguuen
– volume: 4
  start-page: 20
  year: 1998
  ident: R18-3
  publication-title: Mol Vis
  contributor:
    fullname: Rozsa
– volume: 90
  start-page: 4655
  year: 1993
  ident: R27-3
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.90.10.4655
  contributor:
    fullname: Yokoe
– volume: 100
  start-page: 524
  year: 1993
  ident: R5-3
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(13)31615-7
  contributor:
    fullname: Johnson
– volume: 275
  start-page: 668
  year: 1999
  ident: R7-3
  publication-title: Science
  doi: 10.1126/science.275.5300.668
  contributor:
    fullname: Stone
– volume: 76
  start-page: 438
  year: 1998
  ident: R22-3
  publication-title: Am J Med Genet
  doi: 10.1002/(SICI)1096-8628(19980413)76:5<438::AID-AJMG13>3.0.CO;2-N
  contributor:
    fullname: Br??zin
– volume: 4
  start-page: 47
  year: 1993
  ident: R6-3
  publication-title: Nat Genet
  doi: 10.1038/ng0593-47
  contributor:
    fullname: Sheffield
– volume: 328
  start-page: 1097
  year: 1993
  ident: R4-3
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199304153281507
  contributor:
    fullname: Quigley
– volume: 48
  start-page: 1321
  year: 2000
  ident: R13-3
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540004801003
  contributor:
    fullname: Ueda
– volume: 76
  start-page: 41
  year: 2000
  ident: R31-3
  publication-title: Genet Res
  doi: 10.1017/S0016672300004584
  contributor:
    fullname: Kulkarni
– volume: 10
  start-page: 117
  year: 2001
  ident: R33-3
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/10.2.117
  contributor:
    fullname: Jacobson
– volume: 130
  start-page: 165
  year: 2000
  ident: R19-3
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00536-5
  contributor:
    fullname: Shimizu
– volume: 413
  start-page: 349
  year: 1997
  ident: R12-3
  publication-title: Fed Eur Biochem Soc
  doi: 10.1016/S0014-5793(97)00934-4
  contributor:
    fullname: Ortego
– volume: 6
  start-page: 1667
  year: 1997
  ident: R16-3
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/6.10.1667
  contributor:
    fullname: Sarfarazi
– volume: 1
  start-page: 394
  year: 2002
  ident: R32-3
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.M200023-MCP200
  contributor:
    fullname: Green
– volume: 41
  start-page: 729
  year: 2000
  ident: R10-3
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Karali
– volume: 41
  start-page: 3420
  year: 2000
  ident: R11-3
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Swiderski
– volume: 37
  start-page: 301
  year: 2000
  ident: R17-3
  publication-title: J Med Genet
  doi: 10.1136/jmg.37.4.301
  contributor:
    fullname: Vasconcellos
– volume: 42
  start-page: 2324
  year: 2001
  ident: R28-3
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Fautsch
SSID ssj0020221
Score 1.7820207
Snippet PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma....
To evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. Primary...
SourceID proquest
crossref
pubmed
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 104
SubjectTerms Adolescent
Adult
Arginine - genetics
Child
Child, Preschool
Cysteine - genetics
Cytoskeletal Proteins
DNA Mutational Analysis
Eye Proteins - genetics
Female
Glaucoma, Open-Angle - diagnosis
Glaucoma, Open-Angle - genetics
Glaucoma, Open-Angle - surgery
Glycoproteins - genetics
Humans
Intraocular Pressure
Male
Middle Aged
Pedigree
Penetrance
Point Mutation
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
Title Penetrance and Phenotype of the Cys433Arg Myocilin Mutation in a Family Pedigree with Primary Open-Angle Glaucoma
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00061198-200304000-00003
https://www.ncbi.nlm.nih.gov/pubmed/12671463
https://search.proquest.com/docview/73162516
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb5tAEF45jlS1qqq-6z730JuFBCxgcnRdR4lkp1XjVLmhfZFEdaCFoCr_vrMvHkqjtode0ArMgvk-Zmdnv2EQep_kTIKVo55e_48Im3l7KUm8IM1F6rPQl0KFsg-OZ0en6cdltByNXG3Bbt9_RRr2AdYqc_Yf0G47hR3QBsxhC6jD9q9w_wzG66pqEwGUhKvUcVYrBlhc1xEh8-psenkNwCgd-mVjJYfQpm3IA0Y1mItLE6n9bj9KoYptebQ428op-N0N_AF6i3s7OGyUsl9pzVWW5HZbutUHs06v9YnldEFh6r7tnbCWZmForX72IVJ5LHqBpKzbbo_5uUrR0pqEL81Fu6RSWrfYxslL1ajkRUUHYQ7SU8cYywyOpacSgQemO-xRNOzZYVvT2A7ptrDujdHCfIVYu3HBnqYRUTZNp9r7pBshnSrg6FO2f7JaZZvl6WYH7YZg26Ix2p0vDleH7SwfnCI9y3f3a-Vj9kuhv73S0Ce6MdG5h-7_LJV2ov6mUyd6DtDmIXpgocVzQ7lHaCSLx-jO2moznqAfHfMwPHHcMg-XOQbm4ZZ52DEPO-ZhaFNsmIcd87BiHrbMwx3zsKPWU3Syv9wsDjxb0MPjJE6UCEfGufRVBQCRxzCTFkkqZEwiklIeESGoCsX5cZxT4TOfySDhJGUzGQQ8jFJOnqFxURbyBcKqv5DxgCWcRYyHNMwF4QJODkiQSzFBgXukmb3RrKe30DBkLQyZhmGC3rlnn4GRVa8DLWTZ1Jkq7wYTgWSCnhtIuj7DZAbOBpzrDTDKTBpzdhvkL_94rVfobvcevEbjq6qRb9BOLZq3lnK_AIPorKs
link.rule.ids 315,782,786,27934,27935,64551,64571,65346,65366
linkProvider Ovid
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELZKKwFVVR6FslCoDyi3VEmceNNDDmEfXaC7WmkXQU-Wn4tElZTNhqr_vh4nW1pRDlw4xYfYSjxjz-ubGYTeUyO0veW47-L_MRFd_zgl1A9To9JARIFW4MoezbqTb2l_AGVy1lhVSD6rLo7g4a5pGEA7HLAL59mnmTcZfJ1lhdeb9bIzb5qfDJybGkASXj8rf5mVl08yJ5itNQ0sQIBLXfI01ATdogmh9iBs5cP-_MONZWYFmbPMrPLiQ7JpC_lpqzveu9ZdOfaHcrqNdi5LiHdXPxzc_ZbQGj75T7_7FO22Wi3OGzZ8hjZ08Rw9HLdx-z30c2qv1BX08NCYFwpPv-uiBO8vLg22KijuXVUxIflygcdXll2s7ovHdYMSwHbMcdOgA0NnkcVSawz-YzxtSmVgQMX4ebE41_jknNf2H_kL9GU4mPdGftvswZckoQDQ0InRAVSHVyaxVpaiqdIJiUnKZUyU4uCmCZLEcBWIQOiQSpKKrg5DGcWpJC_RZlEW-hXCsF4kZCioFLGQEY-MIlLZySEJjVYdFK5Jxy6aD2W3YvFuL9nNXjK3lx10uKYxswcQoiq80GVdMWj9ZZVE2kH7Del_rxnRrhVEdq5_hxdYk-LK_ka31__4_iF6NJqPT9npx8nnN-ixgxs6bNEB2lwta_0WPahU_a5l-mt27gSp
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3Lb9MwGLegkybQxHNsZcB8QLkFJXHihkMOUdpuhTWK1CHgZPmVIjElW9OA-t_jz0n3EHDgwik-xFZs_-Lv9fP3IfSWlkKbU467Nv4fEjFy38eEun5cqtgTgacVuLJPF6P8SzyeQJqcbQQfLp81l-_gYY9paEA5HLALz5MPCydbZMlXJ598XiS5U6QnE-umBpKEU4ynycYZJ_WPcu2keWLFs7GpAQgEsGqvUENm0B0aGkVhgHbSbHY2u7bPjDiz9plRYVy4ctoTf_ocj38c6640-01FfYj2ftYQ9W6-W9L7LdE1ffxfJ_0EPeo1XJx2kHyK7unqGdqd9zH85-iqMMfrGup5aMwrhYtvuqrBE4zrEht1FGebJiQkXS3xfGOgY_RgPG87xgA2bY67Yh0YqowsV1pj8CXjokubgYEh46bV8kLjkwvempnyffRpOjnPTt2-8IMrSUSBrKGjUnuQKV6VkbG4FI2VjkhIYi5DohQHl40XRSVXnvCE9qkksRhp35dBGEvyAg2qutKHCMN4gZC-oFKEQgY8KBWRynT2iV9qNUT-dgPZZfeh7FZc3q4lu15LZtdyiI63O83MzwgRFl7pum0YlAEzCiMdooMOADdjBnRkhJLp695BBOuuu7K_7dvLf3z_GO0aSLCzWf7xCD2wzENLM3qFButVq1-j-41q3_TI_wUn3QeC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Penetrance+and+phenotype+of+the+Cys433Arg+myocilin+mutation+in+a+family+pedigree+with+primary+open-angle+glaucoma&rft.jtitle=Journal+of+glaucoma&rft.au=de+Vasconcellos%2C+Jos%C3%A9+Paulo+Cabral&rft.au=de+Melo%2C+M%C3%B4nica+Barbosa&rft.au=Schimiti%2C+Rui&rft.au=Costa%2C+Fernando+Ferreira&rft.date=2003-04-01&rft.issn=1057-0829&rft.volume=12&rft.issue=2&rft.spage=104&rft.epage=107&rft_id=info:doi/10.1097%2F00061198-200304000-00003&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1057-0829&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1057-0829&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1057-0829&client=summon